CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Chinese biotech HuidaGene reports early success with first CRISPR brain treatment in 9-year-old with MECP2 duplication ...

An INRS research team has identified a new family of enzymes that can make precise cuts in single-stranded DNA. A few years ...

The recent wave of layoffs and financial troubles at CRISPR-focused startups should not tarnish the promise of CRISPR.

Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research.

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

While much is known about pluripotency—the ability to differentiate into any other cell type in the body and to divide ...

Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...

Colossal Biosciences said it used ancient DNA from the extinct species to create three dire wolf pups named Romulus, Remus ...

In a new development, researchers have successfully created an efficient two-line system for hybrid seed production in ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.